Insider Transactions in Q1 2025 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2025
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
57,938
+10.23%
|
-
|
|
Mar 03
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,809
-2.91%
|
$274,248
$72.1 P/Share
|
|
Mar 03
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.46%
|
$44,352
$72.1 P/Share
|
|
Mar 03
2025
|
Elvia Cowan SVP, FINANCE |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-1.33%
|
$23,400
$72.1 P/Share
|
|
Mar 03
2025
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,984
-1.58%
|
$574,848
$72.1 P/Share
|
|
Mar 03
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,015
-1.95%
|
$217,080
$72.1 P/Share
|
|
Mar 03
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
8,000
-2.48%
|
$584,000
$73.45 P/Share
|
|
Mar 03
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+2.42%
|
$24,000
$3.89 P/Share
|
|
Feb 28
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,270
-0.96%
|
$92,710
$73.02 P/Share
|
|
Feb 28
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-1.1%
|
$34,310
$73.02 P/Share
|
|
Feb 28
2025
|
Elvia Cowan SVP, FINANCE |
SELL
Payment of exercise price or tax liability
|
Direct |
242
-0.98%
|
$17,666
$73.02 P/Share
|
|
Feb 28
2025
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,013
-0.4%
|
$146,949
$73.02 P/Share
|
|
Feb 28
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,139
-1.31%
|
$302,147
$73.02 P/Share
|
|
Feb 28
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,649
+3.43%
|
$412,377
$73.02 P/Share
|
|
Feb 27
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,761
+14.68%
|
-
|
|
Feb 27
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
BUY
Grant, award, or other acquisition
|
Direct |
14,484
+25.33%
|
-
|
|
Feb 27
2025
|
Elvia Cowan SVP, FINANCE |
BUY
Grant, award, or other acquisition
|
Direct |
5,379
+17.9%
|
-
|
|
Feb 27
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,726
+12.4%
|
-
|
|
Feb 18
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
8,000
-3.45%
|
$672,000
$84.11 P/Share
|
|
Feb 18
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+6.38%
|
$40,000
$5.35 P/Share
|
|
Feb 05
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
5,000
-3.19%
|
$445,000
$89.91 P/Share
|
|
Feb 05
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.08%
|
$105,000
$21.41 P/Share
|
|
Feb 03
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
8,000
-1.26%
|
$688,000
$86.87 P/Share
|
|
Feb 03
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.61%
|
$16,000
$2.42 P/Share
|
|
Jan 21
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
8,000
-2.31%
|
$696,000
$87.01 P/Share
|
|
Jan 21
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+6.38%
|
$40,000
$5.35 P/Share
|
|
Jan 15
2025
|
Teri Loxam Director |
SELL
Open market or private sale
|
Direct |
6,250
-7.46%
|
$525,000
$84.54 P/Share
|
|
Jan 15
2025
|
Teri Loxam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+31.77%
|
$137,500
$22.7 P/Share
|
|
Jan 06
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
5,000
-5.15%
|
$425,000
$85.7 P/Share
|
|
Jan 06
2025
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.08%
|
$105,000
$21.41 P/Share
|
|
Jan 02
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
8,000
-1.26%
|
$664,000
$83.67 P/Share
|
|
Jan 02
2025
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.61%
|
$16,000
$2.42 P/Share
|